BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12685432)

  • 1. [Screening colonoscopy for early detection of intestinal cancer].
    Mader U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inquiries. At what age do patients no longer need colorectal cancer screening?
    Tatum P; Mehr D; Easton B
    J Fam Pract; 2001 Jul; 50(7):575-6. PubMed ID: 11485702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early detection of colorectal carcinoma. Are you aware of the screening intervals?].
    Pox C; Schmiegel W
    MMW Fortschr Med; 1999 Sep; 141(36):45-6. PubMed ID: 10904599
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening: now is the time.
    Winawer SJ; Zauber AG
    CMAJ; 2000 Sep; 163(5):543-4; discussion 548. PubMed ID: 11006765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of colorectal cancer screening.
    Hurst JS
    Am Fam Physician; 2003 Mar; 67(6):1188. PubMed ID: 12674445
    [No Abstract]   [Full Text] [Related]  

  • 12. Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
    Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F
    Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and prevention of colorectal cancer].
    Moubayed H; Popescu R; Aellen S; Givel JC; Michetti P; Dorta G
    Rev Med Suisse Romande; 2002 Sep; 122(9):413-6. PubMed ID: 12422468
    [No Abstract]   [Full Text] [Related]  

  • 14. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians.
    Ann Intern Med; 1997 May; 126(10):808-10. PubMed ID: 9148657
    [No Abstract]   [Full Text] [Related]  

  • 15. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; CifalĂ  V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer screening and surveillance controversies.
    Lieberman D
    Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering colorectal screening.
    Mitchell T
    CMAJ; 2003 Apr; 168(9):1110; author reply 1112-3. PubMed ID: 12719304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.